168 related articles for article (PubMed ID: 9972053)
1. Involvement of nitric oxide in cardiovascular effects of cholecystokinin (CCK) in rats.
Wiśniewska RJ; Wiśniewski K
Rocz Akad Med Bialymst; 1998; 43():169-85. PubMed ID: 9972053
[TBL] [Abstract][Full Text] [Related]
2. Influence of nitric oxide on the cardiovascular action of secretin in intact rats. Part B. Does nitric oxide influence the effect of secretin on isolated heart function?
Sitniewska EM; Wiśniewska RJ; Wiśniewski K
Pol J Pharmacol; 2000; 52(5):375-81. PubMed ID: 11334230
[TBL] [Abstract][Full Text] [Related]
3. Influence of nitric oxide on the cardiovascular action of secretin in intact rats. Part A. Does nitric oxide influence the effect of secretin on arterial blood pressure?
Sitniewska EM; Wiśniewska RJ; Wiśniewski K
Pol J Pharmacol; 2000; 52(5):367-73. PubMed ID: 11334229
[TBL] [Abstract][Full Text] [Related]
4. Diabetes-induced changes of nitric oxide influence on the cardiovascular action of secretin.
Sitniewska EM; Wiśniewska RJ; Wiśniewski K
Regul Pept; 2002 May; 105(3):163-72. PubMed ID: 11959370
[TBL] [Abstract][Full Text] [Related]
5. Interaction of cholecystokinin (CCK-8) with agonist and antagonist of beta-adrenergic receptors in circulatory system of diabetic rats.
Wiśniewska RJ; Wiśniewski K
Pol J Pharmacol; 1996; 48(3):293-7. PubMed ID: 9112665
[TBL] [Abstract][Full Text] [Related]
6. Involvement of nitric oxide in both central and peripheral haemodynamic effect of D/L-nebivolol and its enantiomers in rats.
Sacco G; Evangelista S; Criscuoli M; Goso C; Bigioni M; Binaschi M; Manzini S; Maggi CA
Eur J Pharmacol; 2005 Mar; 511(2-3):167-74. PubMed ID: 15792785
[TBL] [Abstract][Full Text] [Related]
7. Long-lasting hypotensive effect in renal hypertensive rats induced by nitric oxide released from a ruthenium complex.
Rodrigues GJ; Pereira AC; Vercesi JA; Lima RG; Silva RS; Bendhack LM
J Cardiovasc Pharmacol; 2012 Aug; 60(2):193-8. PubMed ID: 22635073
[TBL] [Abstract][Full Text] [Related]
8. Effects of sulfated cholecystokinin octapeptide and cholecystokinin tetrapeptide in rat behavior after blockade of nitric oxide synthase by L-NAME.
Hoły Z; Wiśniewski K
Rocz Akad Med Bialymst; 1998; 43():250-70. PubMed ID: 9972062
[TBL] [Abstract][Full Text] [Related]
9. Effect of endogenous nitric oxide on cardiac systolic and diastolic function during ischemia and reperfusion in the rat isolated perfused heart.
Pabla R; Curtis MJ
J Mol Cell Cardiol; 1996 Oct; 28(10):2111-21. PubMed ID: 8930806
[TBL] [Abstract][Full Text] [Related]
10. [Influence of intracerebroventricular injection of sodium nitroprusside L-arginine and NG-nitro-L-arginine on cardiovascular activity in conscious rats].
Liu YL; Li CX; Qiu Y; Qiu XC
Yao Xue Xue Bao; 1997; 32(1):11-4. PubMed ID: 11243210
[TBL] [Abstract][Full Text] [Related]
11. The effect of the nitric oxide synthesis inhibitor L-NAME on amitriptyline-induced hypotension in rats.
Tuncok Y; Kalkan S; Murat N; Arkan F; Guven H; Aygoren O; Kurt S
J Toxicol Clin Toxicol; 2002; 40(2):121-7. PubMed ID: 12126183
[TBL] [Abstract][Full Text] [Related]
12. Novel CCK-dependent vasorelaxing dipeptide, Arg-Phe, decreases blood pressure and food intake in rodents.
Kagebayashi T; Kontani N; Yamada Y; Mizushige T; Arai T; Kino K; Ohinata K
Mol Nutr Food Res; 2012 Sep; 56(9):1456-63. PubMed ID: 22945436
[TBL] [Abstract][Full Text] [Related]
13. Effects of cholecystokinin (CCK-33) and its fragments, C-terminal octapeptide (CCK-8) and C-terminal tetrapeptide (CCK-4), on the circulatory system of diabetic rats.
Fiedorowicz RJ; Wiśniewski K
Pol J Pharmacol Pharm; 1989; 41(6):561-72. PubMed ID: 2485904
[TBL] [Abstract][Full Text] [Related]
14. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
Anderson IK; Drew GM
Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
[TBL] [Abstract][Full Text] [Related]
16. Sodium nitroprusside and L-arginine attenuates ferric nitrilotriacetate-induced oxidative renal injury in rats.
Gupta A; Chander V; Sharma S; Chopra K
Toxicology; 2007 Apr; 232(3):183-91. PubMed ID: 17280760
[TBL] [Abstract][Full Text] [Related]
17. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary arterial pressure and electrocardiograms in broiler chickens infused intravenously with L-NAME, an inhibitor of nitric oxide synthase, or sodium nitroprusside (SNP), a nitric oxide donor.
Weidong S; Xiaolong W; Jinyong W; Ruiping X
Br Poult Sci; 2002 May; 43(2):306-12. PubMed ID: 12047097
[TBL] [Abstract][Full Text] [Related]
19. The involvement of nitric oxide in the anticonvulsant effects of alpha-tocopherol on penicillin-induced epileptiform activity in rats.
Ayyildiz M; Yildirim M; Agar E
Epilepsy Res; 2007 Feb; 73(2):166-72. PubMed ID: 17085015
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxations in the rat isolated mesenteric arterial bed.
McCulloch AI; Randall MD
Br J Pharmacol; 1998 Apr; 123(8):1700-6. PubMed ID: 9605578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
